Carnegie Investment Counsel’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $5.52M | Buy |
|
|||||
|
2024
Q1 | $4.61M | Sell |
|
|||||
|
2023
Q4 | $4.6M | Sell |
|
|||||
|
2023
Q3 | $4.03M | Buy |
|
|||||
|
2023
Q2 | $3.42M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.04M | Sell |
|
|||||
|
2022
Q3 | $3.81M | Sell |
|
|||||
|
2022
Q2 | $5.3M | Buy |
|
|||||
|
2022
Q1 | $5.41M | Sell |
|
|||||
|
2021
Q4 | $8.97M | Sell |
|
|||||
|
2021
Q3 | $13.3M | Buy |
|
|||||
|
2021
Q2 | $19M | Buy |
|
|||||
|
2021
Q1 | $13.3M | Buy |
|
|||||
|
2020
Q4 | $14.4M | Buy |
|
|||||
|
2020
Q3 | $7.47M | Sell |
|
|||||
|
2020
Q2 | $6.74M | Buy |
|
|||||
|
2020
Q1 | $2.81M | Buy |
|
|||||
|
2019
Q4 | $2.29M | Buy |
|
|||||
|
2019
Q3 | $1.03M | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|